Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.
about
Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups.Early prediction of autoimmune (type 1) diabetes.Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood.Insulin resistance in type 1 diabetes.Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.New therapies aimed at the preservation or restoration of beta cell function in type 1 diabetes.Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.Residual C-peptide in type 1 diabetes: what do we really know?Is it time to take a different approach to screening people at high risk for type 1 diabetes?Impact of genetic and non-genetic factors in type 1 diabetes.Vaspin gene in rat adipose tissue: relation to obesity-induced insulin resistance.Detecting type 2 diabetes by a single post-challenge blood sample.Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction.Prevalence of pancreatic autoantibodies in non-diabetic patients with autoimmune thyroid disease and its relation to insulin secretion and glucose tolerance.OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis.Subclinical type 1 diabetes.
P2860
Q33750414-A3D4B459-B044-4C6B-B4B0-D910B5DF1A5FQ33854613-00D259E4-880B-472D-9B19-C96BEB82D467Q34507137-0420DE51-8693-4A38-ABBC-D9F187405BADQ34733637-39EB18B4-52A2-48FC-854F-23D4BFF935CBQ35792511-EA888FAB-EC07-4C7F-BC35-C9AC2C0974B8Q36714327-1C054831-F5E2-4B9C-AA6B-023EB6F194FBQ36945228-B558B9B4-2479-427D-A1DE-8EFC0D42BCB8Q37163792-27856C70-D43B-4D7C-9142-13A6BD023083Q38197230-E9316057-09F4-4045-A5C7-EA9B3D438859Q43143657-C9E80253-2596-46FB-9743-28C9D714572AQ43487193-BDDD6DFB-5FB3-4885-A138-F595C43BE9DCQ44072680-85F65BBE-5662-45ED-8913-7BA199FD1B3DQ44642894-27D1C374-B60C-4120-A736-5444F5E4C41BQ47575059-8090C295-4799-4868-8478-4AEE619D1458Q50881897-F33B136E-EFAB-47D0-B131-8011F23EA370Q51302837-AF06C235-641F-4C8F-92E9-CD64D71D9C33Q55398097-4161B0CF-B9A3-40CA-89D7-04FF2C84B4CA
P2860
Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.
@en
Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.
@nl
type
label
Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.
@en
Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.
@nl
prefLabel
Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.
@en
Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.
@nl
P2093
P921
P1433
P1476
Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.
@en
P2093
C J Greenbaum
D Cuthbertson
Disease Prevention Trial of Type I Diabetes Study Group
J P Krischer
P304
P356
10.2337/DIABETES.50.2.470
P407
P577
2001-02-01T00:00:00Z